Keratoacanthoma: Clinical and histopathologic features of regression

被引:20
作者
Ko, Christine J. [1 ]
McNiff, Jennifer M. [1 ]
Bosenberg, Marcus [1 ]
Choate, Keith A. [1 ]
机构
[1] Yale Univ, Sch Med, New Haven, CT USA
关键词
crateriform; keratoacanthoma; regression; squamous cell carcinoma; squamous lesion; squamous proliferation; SQUAMOUS-CELL CARCINOMA;
D O I
10.1016/j.jaad.2012.02.041
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: The clinical and histopathologic features of regressing keratoacanthomas have not been adequately described in the literature. Objective: "True'' keratoacanthomas (ie, squamous tumors with evidence of spontaneous resolution) were studied clinically and histopathologically. Methods: Nineteen crateriform tumors with a partial biopsy histopathologically compatible with keratoacanthoma were followed over time for correlation with biologic behavior (ie, regression). Tumors displaying spontaneous resolution, arbitrarily defined as a decrease in size of at least 25%, were categorized as keratoacanthomas. Results: Seven regressing keratoacanthomas tended to show flattening before a decrease in diameter. Histopathologically, there was variable epidermal hyperplasia with generally prominent hyperkeratosis, retained crateriform architecture, and dermal fibrosis. Limitations: This study has a small sample size. Conclusions: Regressing keratoacanthomas show persistent crateriform architecture, clinically and histopathologically. Lesions become flatter before decreasing in diameter, and keratinocytes appear banal and lack glassy pink cytoplasm during regression. (J Am Acad Dermatol 2012;67:1008-12.)
引用
收藏
页码:1008 / 1012
页数:5
相关论文
共 11 条
[1]  
ACKERMAN AB, 1984, LIVES LESIONS CHRONO, P102
[2]   Keratoacanthomas and Squamous Cell Carcinomas in Patients Receiving Sorafenib [J].
Arnault, Jean Philippe ;
Wechsler, Janine .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (23) :E59-E61
[3]   THE REGRESSING KERATOACANTHOMA [J].
BLESSING, K ;
ALNAFUSSI, A ;
GORDON, PM .
HISTOPATHOLOGY, 1994, 24 (04) :381-384
[4]   Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation [J].
Chapman, Paul B. ;
Hauschild, Axel ;
Robert, Caroline ;
Haanen, John B. ;
Ascierto, Paolo ;
Larkin, James ;
Dummer, Reinhard ;
Garbe, Claus ;
Testori, Alessandro ;
Maio, Michele ;
Hogg, David ;
Lorigan, Paul ;
Lebbe, Celeste ;
Jouary, Thomas ;
Schadendorf, Dirk ;
Ribas, Antoni ;
O'Day, Steven J. ;
Sosman, Jeffrey A. ;
Kirkwood, John M. ;
Eggermont, Alexander M. M. ;
Dreno, Brigitte ;
Nolop, Keith ;
Li, Jiang ;
Nelson, Betty ;
Hou, Jeannie ;
Lee, Richard J. ;
Flaherty, Keith T. ;
McArthur, Grant A. .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (26) :2507-2516
[5]   Differentiating squamous cell carcinoma from keratoacanthoma using histopathological criteria - Is it possible? A study of 296 cases [J].
Cribier, B ;
Asch, PH ;
Grosshans, E .
DERMATOLOGY, 1999, 199 (03) :208-212
[6]   SOLITARY KERATOACANTHOMA IS A SQUAMOUS-CELL CARCINOMA - 3 EXAMPLES WITH METASTASES [J].
HODAK, E ;
JONES, RE ;
ACKERMAN, AB .
AMERICAN JOURNAL OF DERMATOPATHOLOGY, 1993, 15 (04) :332-342
[7]  
Hodak E, 1993, AM J DERMATOPATH, V15, P43
[8]  
Kirkham N, 2009, LEVERS HISTOPATHOLOG, P837
[9]   Diagnosis and follow-up of keratoacanthoma-like lesions: Clinical-histologic study of 43 cases [J].
Magalhaes, Renata Ferreira ;
Cruvinel, Gabriela Torres ;
Cintra, Georgia Fontes ;
Cintra, Maria Leticia ;
Palu Baltien Ismael, Ana Paula ;
De Moraes, Aparecida Machado .
JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2008, 12 (04) :163-173
[10]   KERATOACANTHOMA - 30 YEAR RETROSPECT [J].
ROOK, A ;
WHIMSTER, I .
BRITISH JOURNAL OF DERMATOLOGY, 1979, 100 (01) :41-47